Discover Great Companies Discover Great Clients
Popularity  2.3万   |   Followers  13   |   Likes  40   |   Feedback  19 Claim this company

Genetic engineering pharmaceuticals, genetic engineering vaccines, and

No.331 Daxing District Popularity Ranking Beijing No.7 Culture Media No.7 Yu Fang Yi Xue No.25 Genetic Engineering No.39 Zhen Duan Yong Yao No.52 Ren Yong Yi Miao No.53 Vaccines No.57 Vaccines Technology No.64 Diagnostic Reagents No.76 Gong Cheng Yan Jiu Center No.93 Sheng Ming Ke Xue Yan Jiu No.97 Innovative Drugs Reagents 国家科技进步奖 博士后工作站 国家重点新产品 高新技术企业 企业技术中心 中关村高新技术企业
More

Company Overview

  • Nature: Listed Company Size: 100-499 employees Founded: 34年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Beijing Tri-Prime Gene Engineering Co., Ltd.。

Development Stage

  • Stage: IPO上市, 北交所。
  • Ranking: Ranked #7 in Beijing Culture Media Company by popularity Ranked #7 in Beijing Yu Fang Yi Xue Company by popularity
  • Honors: 国家科技进步奖 博士后工作站 According to algorithm
  • News: 2024-10-31:三元基因:前三季度营收利润继续双增。
  • Salary: 68.1% of positions earn 10-50K, In 2026 vs last yeargrew by 11%.。Master's salary: ¥39.6K, Doctorate salary: ¥.
  • Recruiting: In 2026 vs 2025remained flat.
  • Requirement: Education: 本科 leads with 69.6%. Experience: 不限 leads with 34.8%.
  • Region: Distributed across 1 regions, 北京: 100%.

About the Company

[Summary] Genetic engineering pharmaceuticals, genetic engineering vaccines, and

I. Company Introduction: Beijing Tri-Prime Gene Engineering Co., Ltd. (abbreviated as: Tri-Prime Gene, stock code: 920344) is a modern biomedical technology enterprise with a registered capital of RMB 121.81 million. It is mainly engaged in the research, development, production, and sales of pharmaceutical and biotechnological products, including genetically engineered pharmaceuticals, genetically engineered vaccines, and diagnostic reagents, as well as related technology trade and technical consulting services. Established in 1992, Tri-Prime Gene is an enterprise named after proprietary genetic engineering technology in China, co-founded by Mr. Hou Yunde, former Vice President of the Chinese Academy of Engineering, and Mr. Cheng Yongqing, one of China's earliest professional managers in high-tech entrepreneurship and venture capital. The main product of Tri-Prime Gene, recombinant human interferon α1b, is a first-class new drug of genetic engineering with independent intellectual property rights in China, used for the treatment of various viral diseases and malignant tumors. Yundesu (trade name of recombinant human interferon α1b) has established a high-quality brand for Chinese genetic drugs and created good economic and social benefits. Tri-Prime Gene has strong R&D capabilities. In 2001, its R&D center was approved by the Ministry of Personnel to establish a postdoctoral research workstation. Currently, it is developing more than ten projects, holds multiple new drugs in clinical research with international advanced level, and owns more than forty invention patents in China, the United States, and other countries. Tri-Prime Gene has successively undertaken more than ten major new drug innovation projects organized by the national and Beijing municipal levels and has obtained more than ten new drug certificates and production approvals. II. Corporate Honors: 1- 2017 National Science and Technology Award (awarded to Academician Hou Yunde of the company) 2- First Prize of National Science and Technology Progress Award (awarded to Academician Hou Yunde of the company) 3- High-tech Enterprise 4- Supporting unit of the "National Key Scientific and Technological Achievements Promotion Plan" 5- A-level Tax Credit Enterprise 6- Beijing Engineering Technology Research Center 7- National Life Science and Technology Talent Training Base 8- Postdoctoral Research Workstation 9- Beijing Patent Demonstration Unit 10- National Key New Product Certificate III. Management Team: Company Founder Hou Yunde: Education: 1955 - Graduated from Medical College of Tongji University, China; 1962 - Graduated from the USSR Academy of Medical Sciences with a Doctor of Medicine degree. Work Experience: 1985-1996: Director of the Institute of Virology, Chinese Academy of Preventive Medicine; Director of the WHO Collaborating Center for Virus Research in China; Director of the State Key Laboratory of Viral Gene Engineering; 1986-1996: Chief Scientist in Biotechnology of the High-Tech Development Plan of the National Science and Technology Commission; 1992-1998: Chairman of Beijing Tri-Prime Gene Engineering Co., Ltd.; 1998-present: Vice President of the Chinese Academy of Engineering, Academician; 2008-present: Chief Technical Officer for the Major Infectious Disease Project of the Ministry of Health. Company Founder and Chairman & General Manager Cheng Yongqing: Education: 1980-1984: Bachelor of Medicine in Pharmacy from West China University of Medical Sciences; 1988-1991: Master of Medicine in Biomedical Technology from Peking Union Medical College Graduate School; 1996-1998: Executive MBA from China Europe International Business School. Work Experience: 1984-1988: Deputy Director of Technology Development Department of Beijing Pharmaceutical Factory; 1990-1998: General Manager of Pharmaceutical and Biotechnology Division of China Science and Technology High-tech Investment Co., Ltd.; General Manager of France Pioneer International Co., Ltd.; 1992-2015: General Manager of Beijing Tri-Prime Gene Engineering Co., Ltd.; 2015-present: Chairman and General Manager of Beijing Tri-Prime Gene Engineering Co., Ltd. IV. Benefits: 1- Two-day weekend, social insurance plus housing fund (six insurances and one fund?) 2- Free working lunch 3- Stock options / year-end bonus 4- Trade union festival benefits, party branch activities 5- Work residence permit application 6- Free training opportunities 7- Free physical examination 8- Public rental housing application

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Tri-Prime Gene Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 北交所
  • Deal: 北交所

Tri-Prime Gene How Fast Is Hiring Growing? (5 open positions)

Manage
Note: How fast is hiring at Beijing Tri-Prime Gene Engineering Co., Ltd. growing? Tri-Prime Gene2026: 21 openings (flat), 2025: 21 openings (down 32%), 2024: 31 openings (down 9%), 2023: 34 openings (up 13%), 2022: 30 openings (up 100%), 2021: 15 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Tri-Prime Gene Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 150%
  • 2024: Up 300%
  • 2023: Down 50%
  • 2022: Down 67%
Tri-Prime Gene Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Beijing Tri-Prime Gene Engineering Co., Ltd. growing? Tri-Prime GeneMaster's recruitment over the years: 2025: 10 openings (up 150%), 2024: 4 openings (up 300%), 2023: 1 openings (down 50%), 2022: 2 openings (down 67%), 2021: 6 openings.

Tri-Prime Gene Doctoral Degree Job Demand Analysis

(More)
-50%
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 67%
  • 2023: Up 100%
  • 2022: Up 200%
Tri-Prime Gene Doctoral Hiring by Year: 2026 — 1 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Beijing Tri-Prime Gene Engineering Co., Ltd. growing? Tri-Prime GeneDoctorate recruitment over the years: 2026: 1 openings (down 50%), 2025: 2 openings (flat), 2024: 2 openings (down 67%), 2023: 6 openings (up 100%), 2022: 3 openings (up 200%), 2021: 1 openings.

Tri-Prime Gene — What Are the Salaries Like? (22 records)

Manage
Tri-Prime Gene Salary Overview
salary range: 6K - 50K, 68.1% of roles pay ¥10-50K
Note: salary statistics are based on 22 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Beijing Tri-Prime Gene Engineering Co., Ltd.?Tri-Prime Gene68.1% of positions earn 10-50K, Fresh graduate salary: ¥。Beijing salary ranking top 45,经营管理类 average salary ¥34.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Tri-Prime Gene

(More)
Are salaries high at Beijing Tri-Prime Gene Engineering Co., Ltd.? We provide: 分装, Workshop, Internet Marketing Specialist, Development Director, Development Manager, Operations, QC, Medical Science Liaison, 发酵工程师, Marketing, Regulatory Affairs Manager, Maintenance Worker, 药物警戒, Marketing Specialist, Marketing Manager, Equipment Maintenance Technician, 财务部副经理, Quality. Click to view detailed salary analysis by job.

Job Category

  • 经营管理类
    47.8% of total 47.8%
  • 生物/制药/化工/环保类
    26.1% of total 26.1%
  • 贸易/物流/采购/运输类
    26.1% of total 26.1%
  • 工厂生产类
    21.7% of total 21.7%

Education

  • 本科
    69.6% of total 69.6%
  • 硕士
    26.1% of total 26.1%
  • 博士
    4.3% of total 4.3%

Experience

  • 不限
    34.8% of total 34.8%
  • 3-5年
    21.7% of total 21.7%
  • 5-10年
    21.7% of total 21.7%
  • 1-3年
    17.4% of total 17.4%
View Detailed Analysis

What does Beijing Tri-Prime Gene Engineering Co., Ltd. require? Who is Tri-Prime Gene hiring? Tri-Prime Gene recruitment: 经营管理类占比最多占47.8%,其次是生物/制药/化工/环保类占26.1%. What education can get in at Tri-Prime Gene? 本科占比最多占69.6%,其次是硕士占26.1%. High education required at Tri-Prime Gene? 硕士占26.1%,博士占4.3%. Work experience required at Tri-Prime Gene? 不限占比最多占34.8%,其次是3-5年占21.7%. Where are the job locations at Tri-Prime Gene? 北京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 12,181万(元)
Legal Representative: 程永庆
Date Established:
Credit Code: 91110000102851949U
Registered Address: 北京市大兴区工业开发区金苑路1号4号楼

Partners & Suppliers

公司委托其进行干扰素制剂的加工生产。 Source
供应商 药品委托生产
作为公司主要经销商,承担江苏、安徽等地的干扰素产品配送与销售。 Source
合作客户 医药分销商
作为公司主要经销商,负责华南区域干扰素产品销售。 Source
合作客户 医药分销商
作为公司主要经销商,承担华东地区干扰素产品的分销。 Source
合作客户 医药分销商
作为公司主要经销商,采购公司重组人干扰素α1b系列产品。 Source
合作客户 医药分销商

People who follow Tri-Prime Gene also follow

Tri-Prime Gene Competitors (Similar Companies)

“基因治疗药物研发商”
“Caring for life, safeguarding health”
进出口/国际贸易 生产 汽车产业链 海外
“Innovative integrated marketing service institution”
软件 系统软件 智慧交通 计算机服务
“Pioneer of China's navigation map industry”
加工 生产基地
“National designated manufacturer of contraceptive drugs”
“PDF电子文档核心技术与应用厂商”
“A leader in the diabetes field”
BPO 金融服务外包 软件 服务外包
“Engaged in R&D and manufacturing of cardiac interventional medical dev”
“A leading AIoT industry application solution provider”
“Dedicated to the research and development of molecularly targeted drug”
系统集成 IT服务 行业信息化 金融IT

Discover Great Companies, Discover Great Clients

北京公司名录 北京“Daxing District”公司名录 北京“医药”公司名录 北京“生命科学”公司名录 北京“诊断试剂”公司名录 北京“疫苗”公司名录 北京“基因工程”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates